SCHEMBL14123724

SCHEMBL14123724

CC(C)Oc1ccc(S(N)(=O)=O)cc1Nc1nc(-c2ccc(N3CCN(C)CC3)cc2)cs1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.47
MEN1 O00255 8/20 0.47
KMT2A Q03164 8/20 0.47
HTT P42858 4/20 0.47
MAPK1 P28482 3/20 0.47
SMN1; SMN2 Q16637 7/20 0.44
TP53 P04637 1/20 0.42
THRB P10828 1/20 0.42
ALOX15 P16050 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ALDH1A1 P00352 4/20 0.42
PHGDH O43175 1/20 0.41
KIT P10721 2/20 0.41
KDM4E B2RXH2 6/20 0.41
RAB9A P51151 1/20 0.41
LMNA P02545 3/20 0.40
HPGD P15428 2/20 0.40
SYK P43405 1/20 0.40
NPSR1 Q6W5P4 2/20 0.39
ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL14054613 0.99 MAPT (0.46) MAPTMEN1KMT2AHTTMAPK1
SCHEMBL14058793 0.92 MAPT (0.46) MAPTMEN1KMT2AHTTMAPK1
SCHEMBL14123654 0.92 MAPT (0.47) MAPTMEN1KMT2AHTTMAPK1
SCHEMBL14123581 0.91 MAPT (0.45) MAPTMEN1KMT2AHTTMAPK1
SCHEMBL14055229 0.91 MAPT (0.46) MAPTMEN1KMT2AHTTMAPK1
SCHEMBL8533646 0.89 MAPT (0.45) MAPTMEN1KMT2AHTTMAPK1
Hydrochloric Acid SCHEMBL6118500 0.89 MAPT (0.44) MAPTMEN1KMT2AHTTMAPK1
SCHEMBL14123630 0.88 KIT (0.49) MAPTMEN1KMT2AHTTMAPK1
SCHEMBL8521156 0.88 SMG1 (0.51) MAPTMEN1KMT2AHTTMAPK1
SCHEMBL14123671 0.88 CCR5 (0.47) MAPTMEN1KMT2AHTTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120302569-A1 PHENYL-THIAZOLYL INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION JANSSEN PHARMACEUTICA NV (BE) 2012-11-29 US disclosed
US-20120302569-A1 PHENYL-THIAZOLYL INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION JANSSEN PHARMACEUTICA NV (BE) 2012-11-29 US disclosed
WO-2012162461-A1 PHENYL-THIAZOLYL INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION JANSSEN PHARMACEUTICA NV (BE) 2012-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120302569-A1 PHENYL-THIAZOLYL INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION MMP9, MMP1, MMP3 MAPT 4078/4885MEN1 3397/4885KMT2A 2808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.